Blastic plasmacytoid dendritic cell neoplasia (BPDCN) is an aggressive hematologic malignancy originating from immature plasmacytoid dendritic cell (PDC) precursors. The initial manifestation of BPDCN often consists of cutaneous lesions. In this educational article, the clinical, histologic and therapeutic aspects of BPDCN are discussed from a dermatologic perspective.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- DERMATOLOGIE PRAXIS
Related Topics
You May Also Like
- Chronic and hard-to-heal wounds
Benefit from the advantages of outpatient negative pressure wound therapy
- COPD
Even a single moderate exacerbation can be a predictor of mortality
- HER2+ metastatic breast cancer
New therapeutic standards with SHR-A 1811
- Angina tonsillaris: clinical management
Conservative therapy or surgery?
- Dermocosmetic for mild to moderate acne
Effects of an anti-pimple cream: randomized split-face study
- Neuro-ophthalmology
Visual Snow Syndrome: From the mysterious disorder to effective treatment options
- Platelet and leukocyte abnormalities
Clonal or reactive causes?
- Gonarthrosis and coxarthrosis: update on conservative treatment